-+ 0.00%
-+ 0.00%
-+ 0.00%

Haixiang Pharmaceutical (002099.SZ) released results for the first three quarters, with a net loss of 136 million yuan to the mother

Zhitongcaijing·10/27/2026 12:17:25
Listen to the news

According to Zhitong Finance App, Haixiang Pharmaceutical (002099.SZ) released its report for the third quarter of 2026. The company achieved operating income of 1,537 billion yuan in the first three quarters, an increase of 12.44% over the previous year; net loss attributable to shareholders of listed companies of 136 million yuan; net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss of $183 million; basic earnings per share -0.09 yuan.